Scientific Review Board

The Scientific Review Board (SRB) comprises distinguished scientists who participate in the review of Institute investigators for reappointment. They work with the Medical Advisory Board in this capacity. Their opinions are advisory to the president.

The SRB is constituted to have a breadth of expertise that encompasses that of the HHMI investigators. Typically 25-35 members are sufficient to span the relevant biomedical subfields. The term of appointment of each member is four years. Appointments are made by the vice president who has responsibility for organization of the investigator reviews, subject to approval by the president.

Each SRB member participates in one, or occasionally two, investigator review meetings per year. They are assigned investigator reviews that are aligned with their own scientific expertise. SRB members are also expected to attend one of the Institute's scientific meetings each year

Scientific Review Board Members

• Wolfhard Almers, Ph.D.
  Senior Scientist
  Vollum Institute
  Oregon Health and Science University
• Spyros Artavanis-Tsakonas,
  Ph.D.
  
  Professor of Cell Biology
  Harvard Medical School
• Mary Beckerle, Ph.D.
  Ralph E. and Willa T. Main Presidential Professor
  Executive Director
  Huntsman Cancer Institute
  University of Utah
• Stephen J. Benkovic, Ph.D.
  Evan Pugh Professor and Eberly Chair in Chemistry
  The Pennsylvania State University
• William A. Catterall, Ph.D.
  
  Professor and Chair
  Department of Pharmacology
  University of Washington School of Medicine
• Alan Hall, Ph.D.
  Chairman
  Cell Biology Program
  Memorial Sloan-Kettering Cancer Center
• Robb Krumlauf, Ph.D.
  Scientific Director
  Stowers Institute for Medical Research
• Lynn Landmesser, Ph.D.
  Garvin Professor and Chair
  Department of Neurosciences
  Case Western Reserve University School of Medicine
• Michael A. Marletta, Ph.D.
  President-Elect
  Cecil H. and Ida M. Green Professor of Chemistry
  The Scripps Research Institute
• Diane Mathis, Ph.D.
  Professor of Pathology
  Harvard Medical School
• W. James Nelson, Ph.D.
  Rudy J. and Daphne Donohue Munzer Professor
  Department of Biology and of Molecular and Cellular Physiology
  James H. Clark Center
  The Bio-X Program
  Stanford University
• Eric N. Olson, Ph.D.
  Professor and Chairman
  Department of Molecular Biology
  University of Texas Southwestern Medical Center at Dallas
• Luis F. Parada, Ph.D.
  Professor and Chairman
  Department of Developmental Biology
  University of Texas Southwestern Medical Center at Dallas
• Hidde Ploegh, Ph.D.
  Member
  Whitehead Institute for Biomedical Research
  Professor of Biology
  Massachusetts Institute of Technology
• Joshua R. Sanes, Ph.D.
  Professor of Molecular and Cellular Biology
  Paul J. Finnegan Family Director, Center for Brain Science
  Harvard University
• Robert T. Sauer, Ph.D.
  Salvador E. Luria Professor
  Department of Biology
  Massachusetts Institute of Technology
• Christopher T. Walsh, Ph.D.
  Hamilton Kuhn Professor
  Department of Biological Chemistry and Molecular Pharmacology
  Harvard Medical School
• Huntington F. Willard, Ph.D.
  Director, Institute for Genome Sciences and Policy
  Nanaline H. Duke Professor of Genome Sciences
  Duke University